Affiliation:
1. Institute of Medical Biostatistics, Epidemiology, and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg-University, Mainz, Germany
2. School of Public Health, University of Health and Allied Sciences, Ho, Ghana
3. Ghana Health Service, Private Mail Bag, Ministries, Accra, Ghana
Abstract
PURPOSE The increasing cancer burden calls for reliable data on current and future associated hospitalizations to enable health care resource planning, especially in low- and middle-income countries. We provide nationwide estimates of the current and future burden of hospitalization because of neoplasms in Ghana. METHODS We conducted secondary data (2012-2017) analysis using nationwide routine administrative inpatient health data from the Ghana Health Service. Multivariable Poisson regression was used to model spatial and temporal hospitalization trends stratified by sex and 5-year age group. In conjunction with official population projections, the model was used to predict future hospitalization up to 2032. RESULTS Out of 2,915,936 hospitalization records extracted for 6 years, 26,627 (1.0%) were for neoplasms, most of them benign (D10-D36, 15,362; 57.7%) and in female patients (20,159; 76%). In total, 9,463 (35.5%) patients with malignancies were mostly female (5,307; 56.1%), had a median age 50 years (interquartile range, 34-66 years) and a median duration of stay of 4 days (interquartile range, 2-8 days). Poisson regression for the malignant cancers revealed an annual increase in hospitalizations with a relative rate of 1.23 (95% CI, 1.19 to 1.27). The estimated hospitalization rate for malignancies of female patients was 1.5 times higher than that of male patients (relative rate, 1.53; 95% CI, 1.00 to 2.34), adjusted for age. We predicted an increase of 67.5% malignant cancer hospitalizations from the empirical years (2012-2017) into the prediction years (2022-2032) in Ghana. CONCLUSION In the absence of a national population-based cancer registry, this nationwide study used secondary health services data on hospitalizations as a proxy for neoplasm morbidity burden. Our results can support planning public health resources and building evidence-based advocacy campaigns for neoplasm-prevention efforts.
Publisher
American Society of Clinical Oncology (ASCO)